The Drug Discovery for Neurodegeneration Confer-enc advances drug discovery for neurodegenerative diseases by educating scientists on the process of trans-lating basic research into novel therapies.
The course is designed to give participants knowledge and relevant resources about this field of scientific investigation and address the associated barriers and challenges.
The program will focus on Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis.
WHAT ATTENDEES WILL LEARN:
Fundamentals of medicinal chemistry for biologists
Basics of high-throughput screening and assay devel-opment
Optimizing lead compounds and conducting in vivo efficacy and safety studies
Utilizing animal models in preclinical development
Requirements for an Investigational New Drug (IND) application
Designing drugs for CNS target classes
Working efficiently with technology transfer offices
Intellectual property strategy: commercial potential, protectability and patentability
Best practices and lessons learned
Accessing resources and funding
We created a special discount code for Columbia that will provide a 20% discount on registration. No limits on the number of users. COLUMB12 is the promo code.
Register and more infor, please click here.